Total Payments
$135,050
2024 Payments
$20,370
Companies
11
Transactions
248
Medicare Patients
1,440
Medicare Billing
$241,627
Payment Breakdown by Category
Other$109,095 (80.8%)
Travel$18,461 (13.7%)
Food & Beverage$7,483 (5.5%)
Education$10.38 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $109,095 | 69 | 80.8% |
| Travel and Lodging | $18,461 | 55 | 13.7% |
| Food and Beverage | $7,483 | 123 | 5.5% |
| Education | $10.38 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $60,598 | 68 | $0 (2024) |
| Lilly USA, LLC | $48,907 | 89 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $21,652 | 28 | $0 (2023) |
| Abbott Laboratories | $2,231 | 34 | $0 (2024) |
| Ancora Heart, Inc. | $690.00 | 6 | $0 (2024) |
| ABIOMED | $437.66 | 11 | $0 (2024) |
| CVRx, Inc. | $221.42 | 3 | $0 (2024) |
| Medtronic Vascular, Inc. | $163.64 | 4 | $0 (2020) |
| Impulse Dynamics (USA) Inc. | $93.25 | 2 | $0 (2024) |
| Medtronic, Inc. | $44.19 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $20,370 | 27 | Boehringer Ingelheim Pharmaceuticals, Inc. ($14,963) |
| 2023 | $47,797 | 97 | Lilly USA, LLC ($34,285) |
| 2022 | $42,556 | 52 | Boehringer Ingelheim Pharmaceuticals, Inc. ($32,335) |
| 2021 | $261.88 | 5 | Abbott Laboratories ($200.67) |
| 2020 | $57.97 | 3 | Abbott Laboratories ($29.00) |
| 2019 | $678.75 | 15 | Abbott Laboratories ($494.84) |
| 2018 | $800.77 | 10 | Abbott Laboratories ($674.96) |
| 2017 | $22,528 | 39 | Novartis Pharmaceuticals Corporation ($21,611) |
All Payment Transactions
248 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/25/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: Heart Failure | ||||||
| 09/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,425.00 | General |
| Category: DIABETES | ||||||
| 09/06/2024 | Impulse Dynamics (USA) Inc. | Optimizer (Device), Optimizer | Food and Beverage | Cash or cash equivalent | $47.23 | General |
| Category: Cardiovascular Device | ||||||
| 08/28/2024 | Impulse Dynamics (USA) Inc. | Optimizer (Device), Optimizer | Food and Beverage | Cash or cash equivalent | $46.02 | General |
| Category: Cardiovascular Device | ||||||
| 08/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $97.39 | General |
| Category: DIABETES | ||||||
| 07/18/2024 | Ancora Heart, Inc. | AccuCinch (Device) | Food and Beverage | Cash or cash equivalent | $344.82 | General |
| Category: Cardiovascular | ||||||
| 07/15/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $880.00 | General |
| Category: Diabetes | ||||||
| 07/11/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $159.91 | General |
| Category: Heart Failure and Hypertension | ||||||
| 07/11/2024 | CVRx, Inc. | Barostim Neo System (Device) | Travel and Lodging | Cash or cash equivalent | $34.38 | General |
| Category: Heart Failure and Hypertension | ||||||
| 07/11/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $27.13 | General |
| Category: Heart Failure and Hypertension | ||||||
| 05/31/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $31.43 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,750.00 | General |
| Category: DIABETES | ||||||
| 04/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $109.98 | General |
| 04/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $28.79 | General |
| Category: DIABETES | ||||||
| 04/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,850.00 | General |
| Category: DIABETES | ||||||
| 04/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,425.00 | General |
| Category: DIABETES | ||||||
| 03/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Travel and Lodging | In-kind items and services | $1,358.69 | General |
| Category: DIABETES | ||||||
| 03/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $122.47 | General |
| Category: DIABETES | ||||||
| 03/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $115.39 | General |
| Category: DIABETES | ||||||
| 02/27/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $2.62 | General |
| Category: Diabetes | ||||||
| 02/23/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Travel and Lodging | Cash or cash equivalent | $48.00 | General |
| Category: Diabetes | ||||||
| 02/23/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | Cash or cash equivalent | $30.79 | General |
| Category: Diabetes | ||||||
| 02/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Travel and Lodging | In-kind items and services | $178.64 | General |
| Category: DIABETES | ||||||
| 02/15/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,740.00 | General |
| Category: Diabetes | ||||||
| 02/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Travel and Lodging | In-kind items and services | $280.12 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 373 | 557 | $261,767 | $59,782 |
| 2022 | 7 | 326 | 499 | $231,116 | $54,264 |
| 2021 | 9 | 383 | 634 | $277,580 | $67,736 |
| 2020 | 11 | 358 | 665 | $238,876 | $59,845 |
Total Patients
1,440
Total Services
2,355
Medicare Billing
$241,627
Procedure Codes
43
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 139 | 217 | $92,876 | $20,476 | 22.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 56 | 84 | $50,400 | $11,322 | 22.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 17 | 46 | $32,798 | $7,752 | 23.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 31 | 31 | $22,847 | $5,207 | 22.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 23 | 36 | $14,328 | $3,496 | 24.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 22 | 22 | $12,276 | $3,034 | 24.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 24 | 26 | $12,428 | $2,869 | 23.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 14 | 14 | $8,120 | $1,982 | 24.4% |
| 93264 | Remote monitoring of pulmonary artery pressure sensor, up to 30 days | Office | 2023 | 16 | 49 | $8,330 | $1,950 | 23.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 20 | 21 | $6,825 | $1,560 | 22.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 11 | 11 | $539.00 | $133.10 | 24.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 102 | 145 | $61,480 | $13,670 | 22.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 60 | 78 | $46,644 | $10,609 | 22.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 17 | 48 | $34,320 | $8,434 | 24.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 34 | 73 | $24,382 | $6,086 | 25.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 28 | 38 | $18,240 | $4,520 | 24.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 21 | 21 | $15,372 | $3,669 | 23.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 30 | 39 | $12,597 | $2,997 | 23.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 18 | 18 | $11,646 | $2,737 | 23.5% |
| 93264 | Remote monitoring of pulmonary artery pressure sensor, up to 30 days | Office | 2022 | 16 | 39 | $6,435 | $1,543 | 24.0% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 29 | 88 | $63,184 | $15,735 | 24.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 88 | 123 | $53,013 | $12,120 | 22.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 55 | 122 | $40,748 | $10,310 | 25.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 51 | 67 | $40,334 | $9,852 | 24.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 41 | 50 | $24,150 | $6,078 | 25.2% |
About Dr. Joshua Remick, M.D
Dr. Joshua Remick, M.D is a Cardiovascular Disease healthcare provider based in Portland, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/20/2007. The National Provider Identifier (NPI) number assigned to this provider is 1861697682.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joshua Remick, M.D has received a total of $135,050 in payments from pharmaceutical and medical device companies, with $20,370 received in 2024. These payments were reported across 248 transactions from 11 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($109,095).
As a Medicare-enrolled provider, Remick has provided services to 1,440 Medicare beneficiaries, totaling 2,355 services with total Medicare billing of $241,627. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Nuclear Medicine, Advanced Heart Failure and Transplant Cardiology
- Location Portland, OR
- Active Since 06/20/2007
- Last Updated 03/24/2021
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1861697682
Products in Payments
- JARDIANCE (Drug) $104,127
- ENTRESTO (Drug) $21,652
- CardioMEMS HF System (Device) $752.68
- Circulatory Support (Device) $695.44
- AccuCinch (Device) $690.00
- HeartMate 3 Left Ventricular Dev (Device) $523.97
- Impella (Device) $437.66
- Barostim Neo System (Device) $221.42
- HeartMate (Device) $198.61
- HeartWare HVAD (Device) $139.63
- Optimizer (Device) $93.25
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $35.86
- HVAD PUMP IMPLANT KIT (Device) $31.05
- EMGALITY (Drug) $25.18
- CARDIOMEMS (Device) $24.06
- Vascepa (Drug) $11.42
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Portland
Jason Wollmuth, M.d, M.D
Cardiovascular Disease — Payments: $751,499
Cardiovascular Disease $751,499
Jacob Abraham, M.d, M.D
Cardiovascular Disease — Payments: $309,316
Cardiovascular Disease $309,316
Amish Desai, Md, MD
Cardiovascular Disease — Payments: $283,454
Cardiovascular Disease $283,454
Douglas Dawley, Md, MD
Cardiovascular Disease — Payments: $207,916
Cardiovascular Disease $207,916
Sergio Fazio, Md, Phd, MD, PHD
Cardiovascular Disease — Payments: $184,755
Cardiovascular Disease $184,755
Stephen Heitner, M.d, M.D
Cardiovascular Disease — Payments: $120,405
Cardiovascular Disease $120,405